{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,14]],"date-time":"2026-07-14T08:05:15Z","timestamp":1784016315016,"version":"3.55.0"},"reference-count":38,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2026,7,1]],"date-time":"2026-07-01T00:00:00Z","timestamp":1782864000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2026,7,1]],"date-time":"2026-07-01T00:00:00Z","timestamp":1782864000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2026,7,1]],"date-time":"2026-07-01T00:00:00Z","timestamp":1782864000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2026,7,1]],"date-time":"2026-07-01T00:00:00Z","timestamp":1782864000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2026,7,1]],"date-time":"2026-07-01T00:00:00Z","timestamp":1782864000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2026,7,1]],"date-time":"2026-07-01T00:00:00Z","timestamp":1782864000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2026,7,1]],"date-time":"2026-07-01T00:00:00Z","timestamp":1782864000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Nanomedicine: Nanotechnology, Biology and Medicine"],"published-print":{"date-parts":[[2026,7]]},"DOI":"10.1016\/j.nano.2026.102977","type":"journal-article","created":{"date-parts":[[2026,6,14]],"date-time":"2026-06-14T17:03:22Z","timestamp":1781456602000},"page":"102977","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":0,"special_numbering":"C","title":["Dual inhibition of glycolysis and epigenetics via a nanodelivery system for colorectal cancer treatment"],"prefix":"10.1016","volume":"75","author":[{"given":"Tingyi","family":"Li","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jingyuan","family":"Zhao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jinnan","family":"Liu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yanwei","family":"Chen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shuai","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.nano.2026.102977_bb0005","doi-asserted-by":"crossref","first-page":"262","DOI":"10.1016\/S2468-1253(21)00426-X","article-title":"The rising tide of early-onset colorectal cancer: a comprehensive review of epidemiology, clinical features, biology, risk factors, prevention, and early detection","volume":"7","author":"Patel","year":"2022","journal-title":"Lancet Gastroenterol Hepatol"},{"key":"10.1016\/j.nano.2026.102977_bb0010","doi-asserted-by":"crossref","first-page":"66","DOI":"10.1186\/s12943-025-02255-4","article-title":"The epigenetic hallmarks of immune cells in cancer","volume":"24","author":"Ji","year":"2025","journal-title":"Mol Cancer"},{"key":"10.1016\/j.nano.2026.102977_bb0015","doi-asserted-by":"crossref","first-page":"355","DOI":"10.1016\/j.cmet.2022.01.007","article-title":"The hallmarks of cancer metabolism: still emerging","volume":"34","author":"Pavlova","year":"2022","journal-title":"Cell Metab"},{"key":"10.1016\/j.nano.2026.102977_bb0020","doi-asserted-by":"crossref","first-page":"203","DOI":"10.1186\/s12943-024-02119-3","article-title":"Altered metabolism in cancer: insights into energy pathways and therapeutic targets","volume":"23","author":"Tufail","year":"2024","journal-title":"Mol Cancer"},{"key":"10.1016\/j.nano.2026.102977_bb0025","doi-asserted-by":"crossref","first-page":"109","DOI":"10.1002\/cac2.12108","article-title":"LncRNA-mediated posttranslational modifications and reprogramming of energy metabolism in cancer","volume":"41","author":"Tan","year":"2021","journal-title":"Cancer Commun (Lond)"},{"key":"10.1016\/j.nano.2026.102977_bb0030","doi-asserted-by":"crossref","first-page":"69","DOI":"10.1038\/s41392-025-02141-x","article-title":"Energy metabolism in health and diseases","volume":"10","author":"Liu","year":"2025","journal-title":"Signal Transduct Target Ther"},{"key":"10.1016\/j.nano.2026.102977_bb0035","doi-asserted-by":"crossref","first-page":"3113","DOI":"10.7150\/ijbs.89942","article-title":"The PI3K\/Akt pathway and glucose metabolism: a dangerous liaison in cancer","volume":"20","author":"Fontana","year":"2024","journal-title":"Int J Biol Sci"},{"key":"10.1016\/j.nano.2026.102977_bb0040","doi-asserted-by":"crossref","first-page":"17","DOI":"10.1007\/978-3-030-65768-0_2","article-title":"Glutamine metabolism in cancer","volume":"1311","author":"Li","year":"2021","journal-title":"Adv Exp Med Biol"},{"key":"10.1016\/j.nano.2026.102977_bb0045","doi-asserted-by":"crossref","first-page":"1216","DOI":"10.1016\/j.semcancer.2022.09.007","article-title":"Tumor glycolysis, an essential sweet tooth of tumor cells","volume":"86","author":"Paul","year":"2022","journal-title":"Semin Cancer Biol"},{"key":"10.1016\/j.nano.2026.102977_bb0050","doi-asserted-by":"crossref","first-page":"761","DOI":"10.1002\/cac2.12549","article-title":"The regulatory roles and clinical significance of glycolysis in tumor","volume":"44","author":"Qiao","year":"2024","journal-title":"Cancer Commun (Lond)"},{"key":"10.1016\/j.nano.2026.102977_bb0055","article-title":"Lactate-lactylation hands between metabolic reprogramming and immunosuppression","volume":"23","author":"Chen","year":"2022","journal-title":"Int J Mol Sci"},{"key":"10.1016\/j.nano.2026.102977_bb0060","doi-asserted-by":"crossref","first-page":"3824","DOI":"10.1016\/j.cell.2024.06.026","article-title":"100 years of the Warburg effect: a cancer metabolism endeavor","volume":"187","author":"Fendt","year":"2024","journal-title":"Cell"},{"key":"10.1016\/j.nano.2026.102977_bb0065","doi-asserted-by":"crossref","first-page":"137","DOI":"10.1186\/s12943-023-01841-8","article-title":"m6A-regulated tumor glycolysis: new advances in epigenetics and metabolism","volume":"22","author":"Yue","year":"2023","journal-title":"Mol Cancer"},{"key":"10.1016\/j.nano.2026.102977_bb0070","doi-asserted-by":"crossref","first-page":"877","DOI":"10.1007\/s13238-021-00846-7","article-title":"Metabolic reprogramming and epigenetic modifications on the path to cancer","volume":"13","author":"Sun","year":"2022","journal-title":"Protein Cell"},{"key":"10.1016\/j.nano.2026.102977_bb0075","doi-asserted-by":"crossref","DOI":"10.1016\/j.lfs.2021.119504","article-title":"Epigenetic modulation and understanding of HDAC inhibitors in cancer therapy","volume":"277","author":"Ramaiah","year":"2021","journal-title":"Life Sci"},{"key":"10.1016\/j.nano.2026.102977_bb0080","doi-asserted-by":"crossref","DOI":"10.1016\/j.cmet.2022.02.015","article-title":"The glucose transporter GLUT3 controls T helper 17 cell responses through glycolytic-epigenetic reprogramming","volume":"34","author":"Hochrein","year":"2022","journal-title":"Cell Metab"},{"key":"10.1016\/j.nano.2026.102977_bb0085","doi-asserted-by":"crossref","DOI":"10.1016\/j.phymed.2024.156324","article-title":"Inhibition of PKM2 by shikonin impedes TGF-\u03b21 expression by repressing histone lactylation to alleviate renal fibrosis","volume":"136","author":"Xiang","year":"2025","journal-title":"Phytomedicine"},{"key":"10.1016\/j.nano.2026.102977_bb0090","doi-asserted-by":"crossref","first-page":"94","DOI":"10.1186\/s12943-024-02009-8","article-title":"ESM1 enhances fatty acid synthesis and vascular mimicry in ovarian cancer by utilizing the PKM2-dependent Warburg effect within the hypoxic tumor microenvironment","volume":"23","author":"Zhang","year":"2024","journal-title":"Mol Cancer"},{"key":"10.1016\/j.nano.2026.102977_bb0095","doi-asserted-by":"crossref","DOI":"10.1016\/j.canlet.2024.216964","article-title":"Tumor-associated macrophage enhances PD-L1-mediated immune escape of bladder cancer through PKM2 dimer-STAT3 complex nuclear translocation","volume":"593","author":"Yu","year":"2024","journal-title":"Cancer Lett"},{"key":"10.1016\/j.nano.2026.102977_bb0100","doi-asserted-by":"crossref","DOI":"10.3390\/nu17193085","article-title":"Shikonin as a dietary phytochemical with multi-target anti-cancer activities: from molecular mechanisms to translational applications","volume":"17","author":"Lew","year":"2025","journal-title":"Nutrients"},{"key":"10.1016\/j.nano.2026.102977_bb0105","doi-asserted-by":"crossref","first-page":"13889","DOI":"10.1021\/acsnano.4c17090","article-title":"Nanosized Shikonin disrupts tumor-cell mismatch repair and synergizes with manganese to sensitize squamous carcinoma to immunotherapy","volume":"19","author":"Yu","year":"2025","journal-title":"ACS Nano"},{"key":"10.1016\/j.nano.2026.102977_bb0110","doi-asserted-by":"crossref","DOI":"10.1016\/j.phrs.2023.106767","article-title":"BRD4: new hope in the battle against glioblastoma","volume":"191","author":"Duan","year":"2023","journal-title":"Pharmacol Res"},{"key":"10.1016\/j.nano.2026.102977_bb0115","article-title":"Versatile Nano-PROTAC-induced epigenetic reader degradation for efficient lung Cancer therapy","volume":"9","author":"Zhang","year":"2022","journal-title":"Adv Sci (Weinh)"},{"key":"10.1016\/j.nano.2026.102977_bb0120","doi-asserted-by":"crossref","first-page":"536","DOI":"10.1186\/s12951-025-03546-0","article-title":"Quercetin combined with shTERT induces apoptosis in ovarian cancer via the P53\/Bax pathway, and RGD-MSN\/QR\/shTERT nanoparticles enhance the therapeutic efficacy","volume":"23","author":"Chen","year":"2025","journal-title":"J Nanobiotechnol"},{"key":"10.1016\/j.nano.2026.102977_bb0125","doi-asserted-by":"crossref","DOI":"10.1002\/adhm.202201884","article-title":"Mesoporous silica nanoparticles-based nanoplatforms: basic construction, current state, and emerging applications in anticancer therapeutics","volume":"12","author":"Feng","year":"2023","journal-title":"Adv Healthc Mater"},{"key":"10.1016\/j.nano.2026.102977_bb0130","doi-asserted-by":"crossref","first-page":"4306","DOI":"10.1021\/acsomega.8b00427","article-title":"Multiple-responsive mesoporous silica nanoparticles for highly accurate drugs delivery to tumor cells","volume":"3","author":"Jin","year":"2018","journal-title":"ACS Omega"},{"key":"10.1016\/j.nano.2026.102977_bb0135","doi-asserted-by":"crossref","first-page":"4428","DOI":"10.1021\/acs.molpharmaceut.2c00374","article-title":"Tuning mesoporous silica nanoparticles in novel avenues of cancer therapy","volume":"19","author":"Shah","year":"2022","journal-title":"Mol Pharm"},{"key":"10.1016\/j.nano.2026.102977_bb0140","doi-asserted-by":"crossref","first-page":"457","DOI":"10.1016\/j.ijbiomac.2021.10.142","article-title":"Polysaccharide\/mesoporous silica nanoparticle-based drug delivery systems: a review","volume":"193","author":"Kuang","year":"2021","journal-title":"Int J Biol Macromol"},{"key":"10.1016\/j.nano.2026.102977_bb0145","doi-asserted-by":"crossref","DOI":"10.1002\/mabi.202200565","article-title":"Oxidized dextran\/chitosan hydrogel engineered with tetrasulfide-bridged silica nanoparticles for postsurgical treatment","volume":"24","author":"Hu","year":"2024","journal-title":"Macromol Biosci"},{"key":"10.1016\/j.nano.2026.102977_bb0150","doi-asserted-by":"crossref","first-page":"28","DOI":"10.1186\/s12943-021-01316-8","article-title":"The cancer metabolic reprogramming and immune response","volume":"20","author":"Xia","year":"2021","journal-title":"Mol Cancer"},{"key":"10.1016\/j.nano.2026.102977_bb0155","doi-asserted-by":"crossref","DOI":"10.1016\/j.ccell.2022.12.008","article-title":"Intersection of immune and oncometabolic pathways drives cancer hyperprogression during immunotherapy","volume":"41","author":"Li","year":"2023","journal-title":"Cancer Cell"},{"key":"10.1016\/j.nano.2026.102977_bb0160","doi-asserted-by":"crossref","first-page":"193","DOI":"10.1016\/j.cmet.2023.12.003","article-title":"Metabolic switch regulates lineage plasticity and induces synthetic lethality in triple-negative breast cancer","volume":"36","author":"Zhang","year":"2024","journal-title":"Cell Metab"},{"key":"10.1016\/j.nano.2026.102977_bb0165","doi-asserted-by":"crossref","first-page":"692","DOI":"10.1186\/s12951-024-02967-7","article-title":"Dual targeting and bioresponsive nano-PROTAC induced precise and effective lung cancer therapy","volume":"22","author":"Guan","year":"2024","journal-title":"J Nanobiotechnol"},{"key":"10.1016\/j.nano.2026.102977_bb0170","doi-asserted-by":"crossref","DOI":"10.1016\/j.molcel.2023.06.032","article-title":"Distinct layers of BRD4-PTEFb reveal bromodomain-independent function in transcriptional regulation","volume":"83","author":"Zheng","year":"2023","journal-title":"Mol Cell"},{"key":"10.1016\/j.nano.2026.102977_bb0175","doi-asserted-by":"crossref","first-page":"90","DOI":"10.1186\/s12943-024-02008-9","article-title":"Positive feedback regulation between glycolysis and histone lactylation drives oncogenesis in pancreatic ductal adenocarcinoma","volume":"23","author":"Li","year":"2024","journal-title":"Mol Cancer"},{"key":"10.1016\/j.nano.2026.102977_bb0180","doi-asserted-by":"crossref","DOI":"10.1002\/adfm.201801961","article-title":"Core\u2013satellite mesoporous silica\u2013gold nanotheranostics for biological stimuli triggered multimodal cancer therapy","volume":"28","author":"Jin","year":"2018","journal-title":"Adv Funct Mater"},{"key":"10.1016\/j.nano.2026.102977_bb0185","doi-asserted-by":"crossref","DOI":"10.1016\/j.drup.2024.101170","article-title":"Autophagy in cancer development, immune evasion, and drug resistance","volume":"78","author":"Niu","year":"2025","journal-title":"Drug Resist Updat"},{"key":"10.1016\/j.nano.2026.102977_bb0190","doi-asserted-by":"crossref","DOI":"10.1016\/j.engmed.2025.100115","article-title":"Assembly\/disassembly-based targeting protein degradation systems for cancer therapy","volume":"3","author":"Yan","year":"2026","journal-title":"EngMedicine"}],"container-title":["Nanomedicine: Nanotechnology, Biology and Medicine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S154996342600078X?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S154996342600078X?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,7,14]],"date-time":"2026-07-14T07:26:11Z","timestamp":1784013971000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S154996342600078X"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,7]]},"references-count":38,"alternative-id":["S154996342600078X"],"URL":"https:\/\/doi.org\/10.1016\/j.nano.2026.102977","relation":{},"ISSN":["1549-9634"],"issn-type":[{"value":"1549-9634","type":"print"}],"subject":[],"published":{"date-parts":[[2026,7]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Dual inhibition of glycolysis and epigenetics via a nanodelivery system for colorectal cancer treatment","name":"articletitle","label":"Article Title"},{"value":"Nanomedicine: Nanotechnology, Biology and Medicine","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.nano.2026.102977","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2026 Elsevier Inc. All rights are reserved, including those for text and data mining, AI training, and similar technologies.","name":"copyright","label":"Copyright"}],"article-number":"102977"}}